PubMed中文版
| PubMed ID | 41405876 |
|---|---|
| 发表日期 | 2025-12-17 |
| 作者 | |
| 文献标题 | Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: Research Summary. |
| 原始出处 | JAMA |
| 影响因子 | 55 期刊引文指标 11.47 |
| PubMed ID | 41359335 |
|---|---|
| 发表日期 | 2025-12-01 |
| 作者 | Cantoni V, Casula EP, Tarantino B, Cupidi C, Huber N, Altomare D, Premi E, Zummo E, Esposito R, Leonardi C, Herukka SK, Solje E, Ferrari A, Cotelli MS, Gasparotti R, Martorana A, Fracassi C, Santarnecchi E, Koch G, Haapasalo A, Grassi M, Benussi A, Borroni B. |
| 文献标题 | Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial. |
| 原始出处 | JAMA Netw Open |
| 影响因子 | 9.7 期刊引文指标 2.95 |
| PubMed ID | 41082199 |
|---|---|
| 发表日期 | 2025-12-01 |
| 作者 | Lu M, Kim MJ, Collins EC, Shcherbinin S, Ellinwood AK, Yokoi Y, Brooks DA, Hansson O, Knopman DS, Sims JR, Mintun MA. |
| 文献标题 | Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial. |
| 原始出处 | JAMA Neurol |
| 影响因子 | 21.3 期刊引文指标 6.16 |
| PubMed ID | 41312794 |
|---|---|
| 发表日期 | 2025-11-28 |
| 作者 | Healy M, Thomas S, Brodtmann A. |
| 文献标题 | Magnetic resonance imaging eligibility for anti-amyloid monoclonal antibody treatment for Alzheimer disease: a single-centre retrospective review for service planning. |
| 原始出处 | Intern Med J |
| 影响因子 | 1.5 期刊引文指标 0.47 |
| PubMed ID | 41290365 |
|---|---|
| 发表日期 | 2025-11-25 |
| 作者 | Chiotis K, Wang Y, La Joie R, Rabinovici GD. |
| 文献标题 | The Role of Amyloid-β and Tau PET in the New Era of Alzheimer Disease Therapies. |
| 原始出处 | J Nucl Med |
| 影响因子 | 9.1 期刊引文指标 2.88 |
| PubMed ID | 41252538 |
|---|---|
| 发表日期 | 2025-11-18 |
| 作者 | Depp C, Holden J, Granholm E. |
| 文献标题 | Digital Measurement of Subjective Experiences in Alzheimer Disease and Related Dementias (AD/ADRD). |
| 原始出处 | JMIR Aging |
| 影响因子 | 4.8 期刊引文指标 1.11 |
| PubMed ID | 41176545 |
|---|---|
| 发表日期 | 2025-11-02 |
| 作者 | El Hajj W, Pujo-Menjouet L, Tine LM, Volpert V. |
| 文献标题 | Modelling of anti-inflammatory treatment in the Alzheimer disease: optimal regimen and outcome. |
| 原始出处 | Bull Math Biol |
| 影响因子 | 2.2 期刊引文指标 0.65 |
| PubMed ID | 40955711 |
|---|---|
| 发表日期 | 2025-09-16 |
| 作者 | Tan A, Wang Z, Aumont E, Li A, Qin X, Yang X, Feng W, Yang J, Li X, Xiao J, Zhou B, Xing Y, Yi Y, Li J. |
| 文献标题 | Determinants of Treatment Willingness and Willingness-to-Pay for Lecanemab in China: A Network Analysis. |
| 原始出处 | Alzheimer Dis Assoc Disord |
| 影响因子 | 1.4 期刊引文指标 0.6 |
| PubMed ID | 40855593 |
|---|---|
| 发表日期 | 2025-08-28 |
| 作者 | Foreman RM, Rodriguez M. |
| 文献标题 | Understanding the correlative relationship between obesity and Alzheimer disease. |
| 原始出处 | Nurse Pract |
| 影响因子 | 0.9 期刊引文指标 0.35 |
| PubMed ID | 40354064 |
|---|---|
| 发表日期 | 2025-07-01 |
| 作者 | Paczynski M, Hofmann A, Posey Z, Gregersen M, Rudman M, Ellington D, Aldinger M, Musiek ES, Holtzman DM, Bateman RJ, Long JM, Ghoshal N, Carr DB, Dow A, Namazie-Kummer S, Jana N, Xiong C, Morris JC, Benzinger TLS, Schindler SE, Snider BJ. |
| 文献标题 | Lecanemab Treatment in a Specialty Memory Clinic. |
| 原始出处 | JAMA Neurol |
| 影响因子 | 21.3 期刊引文指标 6.16 |
| PubMed ID | 39805666 |
|---|---|
| 发表日期 | 2025-07-01 |
| 作者 | Ricaurte-Fajardo A, Ivanidze J, Zhang D, Mahmud M, Yasen W, Ravdin L, Pahlajani S, Leon M, Nordvig AS, Chiang GC. |
| 文献标题 | Antiamyloid Therapy and Cerebral Blood Flow Changes on MRI: A Potential Longitudinal Biomarker of Treatment Response? |
| 原始出处 | AJNR Am J Neuroradiol |
| 影响因子 | 3.7 期刊引文指标 1.02 |
| PubMed ID | 40736488 |
|---|---|
| 发表日期 | 2025-07-01 |
| 作者 | Johnston EM, Lounsbery JL. |
| 文献标题 | Benzgalantamine (Zunveyl) for the Treatment of Mild to Moderate Alzheimer Disease. |
| 原始出处 | Am Fam Physician |
| 影响因子 | 3.5 期刊引文指标 1.63 |
| PubMed ID | 40552995 |
|---|---|
| 发表日期 | 2025-06-01 |
| 作者 | Shepherd TM. |
| 文献标题 | Imaging the Treatment of Alzheimer Disease: 2030 Could Look Very Different. |
| 原始出处 | Radiology |
| 影响因子 | 15.2 期刊引文指标 4.16 |
| PubMed ID | 40222353 |
|---|---|
| 发表日期 | 2025-04-14 |
| 作者 | Felbecker A, Felbecker A, Rouaud O, Rouaud O, Lathuiliere A, Allali G, Sollberger M, Meyer-Heim T, Monsch AU, Lövblad KO, Becker S, Barro-Belaygues N, Popp J, Bürge M, Lindheimer K, Gietl A, Jung HH, Georgescu D, Meyer R, Frisoni GB. |
| 文献标题 | Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland. |
| 原始出处 | Neurodegener Dis |
| 影响因子 | 2.6 期刊引文指标 0.62 |
| PubMed ID | 40042516 |
|---|---|
| 发表日期 | 2025-03-01 |
| 作者 | Dohl J, Treadwell Z, Norris C, Head E. |
| 文献标题 | Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome. |
| 原始出处 | Alzheimers Dement |
| 影响因子 | 11.1 期刊引文指标 3.34 |
| PubMed ID | 40009384 |
|---|---|
| 发表日期 | 2025-02-03 |
| 作者 | Matt E, Mitterwallner M, Radjenovic S, Grigoryeva D, Weber A, Stögmann E, Domitner A, Zettl A, Osou S, Beisteiner R. |
| 文献标题 | Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease: A Randomized Clinical Trial. |
| 原始出处 | JAMA Netw Open |
| 影响因子 | 9.7 期刊引文指标 2.95 |
| PubMed ID | 39792490 |
|---|---|
| 发表日期 | 2024-11-01 |
| 作者 | Necula BR, Necula RD, Petric PS, Ifteni PI, Irimie M, Dima L. |
| 文献标题 | EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years? |
| 原始出处 | Am J Ther |
| 影响因子 | 2.5 期刊引文指标 0.61 |
| PubMed ID | 39312316 |
|---|---|
| 发表日期 | 2024-09-01 |
| 作者 | Deng X, Li D. |
| 文献标题 | Effect of long-term pharmacological treatments on Alzheimer disease: A systematic review and network meta-analysis. |
| 原始出处 | Medicine (Baltimore) |
| 影响因子 | 1.4 期刊引文指标 0.37 |
| PubMed ID | 38411409 |
|---|---|
| 发表日期 | 2024-02-01 |
| 作者 | Scott IA. |
| 文献标题 | Monoclonal antibodies for treating early Alzheimer disease-a commentary on recent 'positive' trials. |
| 原始出处 | Age Ageing |
| 影响因子 | 7.1 期刊引文指标 1.34 |
| PubMed ID | 37930677 |
|---|---|
| 发表日期 | 2023-12-01 |
| 作者 | Ballard C. |
| 文献标题 | Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimer Disease. |
| 原始出处 | JAMA Neurol |
| 影响因子 | 21.3 期刊引文指标 6.16 |